ID   KAPCA_HUMAN             Reviewed;         343 AA.
AC   P17612-2;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   12-OCT-2022, entry version 242.
DE   RecName: Full=Isoform 2 of cAMP-dependent protein kinase catalytic subunit alpha;
DE            Short=PKA C-alpha;
DE            EC=2.7.11.11;
GN   Name=PRKACA; Synonyms=PKACA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2843813; DOI=10.1093/nar/16.16.8189;
RA   Maldonado F., Hanks S.K.;
RT   "A cDNA clone encoding human cAMP-dependent protein kinase catalytic
RT   subunit C alpha.";
RL   Nucleic Acids Res. 16:8189-8190(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JUN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-189 (ISOFORM 2), SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=10906071; DOI=10.1095/biolreprod63.2.607;
RA   Reinton N., Orstavik S., Haugen T.B., Jahnsen T., Tasken K., Skalhegg B.S.;
RT   "A novel isoform of human cyclic 3',5'-adenosine monophosphate-dependent
RT   protein kinase, c alpha-s, localizes to sperm midpiece.";
RL   Biol. Reprod. 63:607-611(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-152 (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=10982398; DOI=10.1091/mbc.11.9.3031;
RA   San Agustin J.T., Wilkerson C.G., Witman G.B.;
RT   "The unique catalytic subunit of sperm cAMP-dependent protein kinase is the
RT   product of an alternative C-alpha mRNA expressed specifically in
RT   spermatogenic cells.";
RL   Mol. Biol. Cell 11:3031-3044(2000).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-39 (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=10841548; DOI=10.1073/pnas.97.12.6433;
RA   Desseyn J.-L., Burton K.A., McKnight G.S.;
RT   "Expression of a nonmyristylated variant of the catalytic subunit of
RT   protein kinase A during male germ-cell development.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:6433-6438(2000).
RN   [9]
RP   AUTOPHOSPHORYLATION, PHOSPHORYLATION AT THR-196, PHOSPHORYLATION AT THR-198
RP   BY PDK1, AND MUTAGENESIS OF ARG-195; GLY-201 AND THR-202.
RX   PubMed=12372837; DOI=10.1074/jbc.m204970200;
RA   Moore M.J., Kanter J.R., Jones K.C., Taylor S.S.;
RT   "Phosphorylation of the catalytic subunit of protein kinase A.
RT   Autophosphorylation versus phosphorylation by phosphoinositide-dependent
RT   kinase-1.";
RL   J. Biol. Chem. 277:47878-47884(2002).
RN   [10]
RP   INTERACTION WITH RAB13.
RX   PubMed=15096524; DOI=10.1083/jcb.200312118;
RA   Koehler K., Louvard D., Zahraoui A.;
RT   "Rab13 regulates PKA signaling during tight junction assembly.";
RL   J. Cell Biol. 165:175-180(2004).
RN   [11]
RP   FUNCTION AS NFKB1 KINASE.
RX   PubMed=15642694; DOI=10.1074/jbc.m412180200;
RA   Guan H., Hou S., Ricciardi R.P.;
RT   "DNA binding of repressor nuclear factor-kappaB p50/p50 depends on
RT   phosphorylation of Ser337 by the protein kinase A catalytic subunit.";
RL   J. Biol. Chem. 280:9957-9962(2005).
RN   [12]
RP   FUNCTION AS CLDN3 KINASE.
RX   PubMed=15905176; DOI=10.1074/jbc.m502003200;
RA   D'Souza T., Agarwal R., Morin P.J.;
RT   "Phosphorylation of claudin-3 at threonine 192 by cAMP-dependent protein
RT   kinase regulates tight junction barrier function in ovarian cancer cells.";
RL   J. Biol. Chem. 280:26233-26240(2005).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH AICDA.
RX   PubMed=16387847; DOI=10.1073/pnas.0509969103;
RA   Pasqualucci L., Kitaura Y., Gu H., Dalla-Favera R.;
RT   "PKA-mediated phosphorylation regulates the function of activation-induced
RT   deaminase (AID) in B cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:395-400(2006).
RN   [14]
RP   FUNCTION IN PROTEASOME REGULATION, AND FUNCTION AS PSMC5/RPT6 KINASE.
RX   PubMed=17565987; DOI=10.1074/jbc.m702439200;
RA   Zhang F., Hu Y., Huang P., Toleman C.A., Paterson A.J., Kudlow J.E.;
RT   "Proteasome function is regulated by cyclic AMP-dependent protein kinase
RT   through phosphorylation of Rpt6.";
RL   J. Biol. Chem. 282:22460-22471(2007).
RN   [15]
RP   FUNCTION AS RYR2 KINASE.
RX   PubMed=17693412; DOI=10.1074/jbc.m703510200;
RA   Xiao B., Tian X., Xie W., Jones P.P., Cai S., Wang X., Jiang D., Kong H.,
RA   Zhang L., Chen K., Walsh M.P., Cheng H., Chen S.R.W.;
RT   "Functional consequence of protein kinase A-dependent phosphorylation of
RT   the cardiac ryanodine receptor: sensitization of store overload-induced
RT   Ca2+ release.";
RL   J. Biol. Chem. 282:30256-30264(2007).
RN   [16]
RP   PHOSPHORYLATION, AND ACTIVITY REGULATION.
RX   PubMed=17909264; DOI=10.1677/jme-07-0048;
RA   Ichikawa T., Horie-Inoue K., Ikeda K., Blumberg B., Inoue S.;
RT   "Vitamin K2 induces phosphorylation of protein kinase A and expression of
RT   novel target genes in osteoblastic cells.";
RL   J. Mol. Endocrinol. 39:239-247(2007).
RN   [17]
RP   FUNCTION AS ALPHA-DIFLUOROMETHYLORNITHINE ANTAGONIST.
RX   PubMed=17333334; DOI=10.1007/s10549-007-9536-5;
RA   Xu H., Washington S., Verderame M.F., Manni A.;
RT   "Activation of protein kinase A (PKA) signaling mitigates the
RT   antiproliferative and antiinvasive effects of alpha-difluoromethylornithine
RT   in breast cancer cells.";
RL   Breast Cancer Res. Treat. 107:63-70(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-49 AND SER-339, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [19]
RP   FUNCTION, AND INTERACTION WITH APOBEC3G.
RX   PubMed=18836454; DOI=10.1038/nsmb.1497;
RA   Shirakawa K., Takaori-Kondo A., Yokoyama M., Izumi T., Matsui M., Io K.,
RA   Sato T., Sato H., Uchiyama T.;
RT   "Phosphorylation of APOBEC3G by protein kinase A regulates its interaction
RT   with HIV-1 Vif.";
RL   Nat. Struct. Mol. Biol. 15:1184-1191(2008).
RN   [20]
RP   ACTIVITY REGULATION, AND MUTAGENESIS OF TYR-205.
RX   PubMed=18178622; DOI=10.1073/pnas.0709214104;
RA   Masterson L.R., Mascioni A., Traaseth N.J., Taylor S.S., Veglia G.;
RT   "Allosteric cooperativity in protein kinase A.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:506-511(2008).
RN   [21]
RP   SUBCELLULAR LOCATION.
RX   PubMed=19210988; DOI=10.1016/j.yexcr.2008.12.026;
RA   Yan X., Walkiewicz M., Carlson J., Leiphon L., Grove B.;
RT   "Gravin dynamics regulates the subcellular distribution of PKA.";
RL   Exp. Cell Res. 315:1247-1259(2009).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [24]
RP   FUNCTION IN PLATELETS, FUNCTION AS VASP KINASE, AND INTERACTION WITH NFKB1;
RP   NFKB2 AND NFKBIA.
RX   PubMed=20356841; DOI=10.1074/jbc.m109.077602;
RA   Gambaryan S., Kobsar A., Rukoyatkina N., Herterich S., Geiger J.,
RA   Smolenski A., Lohmann S.M., Walter U.;
RT   "Thrombin and collagen induce a feedback inhibitory signaling pathway in
RT   platelets involving dissociation of the catalytic subunit of protein kinase
RT   A from an NFkappaB-IkappaB complex.";
RL   J. Biol. Chem. 285:18352-18363(2010).
RN   [25]
RP   FUNCTION IN OSTEOBLAST DIFFERENTIATION, AND ACTIVITY REGULATION.
RX   PubMed=19949837; DOI=10.1007/s11010-009-0344-6;
RA   Wang W., Zhang X., Zheng J., Yang J.;
RT   "High glucose stimulates adipogenic and inhibits osteogenic differentiation
RT   in MG-63 cells through cAMP/protein kinase A/extracellular signal-regulated
RT   kinase pathway.";
RL   Mol. Cell. Biochem. 338:115-122(2010).
RN   [26]
RP   FUNCTION IN PHOSPHORYLATION OF HSF1, INTERACTION WITH HSF1, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=21085490; DOI=10.1371/journal.pone.0013830;
RA   Murshid A., Chou S.D., Prince T., Zhang Y., Bharti A., Calderwood S.K.;
RT   "Protein kinase A binds and activates heat shock factor 1.";
RL   PLoS ONE 5:E13830-E13830(2010).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [28]
RP   FUNCTION AS RORA KINASE.
RX   PubMed=21514275; DOI=10.1016/j.bbrc.2011.04.046;
RA   Ermisch M., Firla B., Steinhilber D.;
RT   "Protein kinase A activates and phosphorylates ROR?4 in vitro and takes
RT   part in ROR? activation by CaMK-IV.";
RL   Biochem. Biophys. Res. Commun. 408:442-446(2011).
RN   [29]
RP   FUNCTION AS KINASE, TISSUE SPECIFICITY, AND INTERACTION WITH PRKAR1A/PKR1
RP   AND PRKAR2A/PKR2.
RX   PubMed=21812984; DOI=10.1186/1471-2091-12-40;
RA   Vetter M.M., Zenn H.-M., Mendez E., van den Boom H., Herberg F.W.,
RA   Skaalhegg B.S.;
RT   "The testis-specific C?2 subunit of PKA is kinetically indistinguishable
RT   from the common C?1 subunit of PKA.";
RL   BMC Biochem. 12:40-40(2011).
RN   [30]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=21423175; DOI=10.1038/ncb2209;
RA   Lignitto L., Carlucci A., Sepe M., Stefan E., Cuomo O., Nistico R.,
RA   Scorziello A., Savoia C., Garbi C., Annunziato L., Feliciello A.;
RT   "Control of PKA stability and signalling by the RING ligase praja2.";
RL   Nat. Cell Biol. 13:412-422(2011).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [32]
RP   MYRISTOYLATION AT GLY-2, CLEAVAGE OF INITIATOR METHIONINE, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=25255805; DOI=10.1038/ncomms5919;
RA   Thinon E., Serwa R.A., Broncel M., Brannigan J.A., Brassat U., Wright M.H.,
RA   Heal W.P., Wilkinson A.J., Mann D.J., Tate E.W.;
RT   "Global profiling of co- and post-translationally N-myristoylated proteomes
RT   in human cells.";
RL   Nat. Commun. 5:4919-4919(2014).
RN   [33]
RP   INVOLVEMENT IN PPNAD4, VARIANT PPNAD4 ARG-206, AND CHARACTERIZATION OF
RP   VARIANT PPNAD4 ARG-206.
RX   PubMed=24747643; DOI=10.1038/ng.2956;
RA   Goh G., Scholl U.I., Healy J.M., Choi M., Prasad M.L., Nelson-Williams C.,
RA   Kunstman J.W., Kuntsman J.W., Korah R., Suttorp A.C., Dietrich D.,
RA   Haase M., Willenberg H.S., Staalberg P., Hellman P., Akerstroem G.,
RA   Bjoerklund P., Carling T., Lifton R.P.;
RT   "Recurrent activating mutation in PRKACA in cortisol-producing adrenal
RT   tumors.";
RL   Nat. Genet. 46:613-617(2014).
RN   [34]
RP   MYRISTOYLATION AT GLY-2, CLEAVAGE OF INITIATOR METHIONINE, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=25807930; DOI=10.1002/anie.201500342;
RA   Broncel M., Serwa R.A., Ciepla P., Krause E., Dallman M.J., Magee A.I.,
RA   Tate E.W.;
RT   "Multifunctional reagents for quantitative proteome-wide analysis of
RT   protein modification in human cells and dynamic profiling of protein
RT   lipidation during vertebrate development.";
RL   Angew. Chem. Int. Ed. 54:5948-5951(2015).
RN   [35]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 15-351, AND PHOSPHORYLATION AT
RP   THR-198 AND SER-339.
RX   PubMed=16765046; DOI=10.1016/j.bmcl.2006.05.092;
RA   Lin X., Murray J.M., Rico A.C., Wang M.X., Chu D.T., Zhou Y.,
RA   Del Rosario M., Kaufman S., Ma S., Fang E., Crawford K., Jefferson A.B.;
RT   "Discovery of 2-pyrimidyl-5-amidothiophenes as potent inhibitors for AKT:
RT   synthesis and SAR studies.";
RL   Bioorg. Med. Chem. Lett. 16:4163-4168(2006).
RN   [37]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS), PHOSPHORYLATION AT THR-198 AND
RP   SER-339, AND ACTIVITY REGULATION.
RX   PubMed=20137943; DOI=10.1016/j.bmcl.2010.01.067;
RA   Zeng Q., Allen J.G., Bourbeau M.P., Wang X., Yao G., Tadesse S.,
RA   Rider J.T., Yuan C.C., Hong F.-T., Lee M.R., Zhang S., Lofgren J.A.,
RA   Freeman D.J., Yang S., Li C., Tominey E., Huang X., Hoffman D.,
RA   Yamane H.K., Fotsch C., Dominguez C., Hungate R., Zhang X.;
RT   "Azole-based inhibitors of AKT/PKB for the treatment of cancer.";
RL   Bioorg. Med. Chem. Lett. 20:1559-1564(2010).
RN   [38]
RP   X-RAY CRYSTALLOGRAPHY (2.49 ANGSTROMS), PHOSPHORYLATION AT THR-198 AND
RP   SER-339, AND ACTIVITY REGULATION.
RX   PubMed=20481595; DOI=10.1021/jm1003842;
RA   Freeman-Cook K.D., Autry C., Borzillo G., Gordon D., Barbacci-Tobin E.,
RA   Bernardo V., Briere D., Clark T., Corbett M., Jakubczak J., Kakar S.,
RA   Knauth E., Lippa B., Luzzio M.J., Mansour M., Martinelli G., Marx M.,
RA   Nelson K., Pandit J., Rajamohan F., Robinson S., Subramanyam C., Wei L.,
RA   Wythes M., Morris J.;
RT   "Design of selective, ATP-competitive inhibitors of Akt.";
RL   J. Med. Chem. 53:4615-4622(2010).
RN   [39]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) IN COMPLEX WITH ADENOSINE ANALOG,
RP   PHOSPHORYLATION AT SER-11; THR-198 AND SER-339, AND ACTIVITY REGULATION.
RX   PubMed=20732331; DOI=10.1016/j.jmb.2010.08.028;
RA   Pflug A., Rogozina J., Lavogina D., Enkvist E., Uri A., Engh R.A.,
RA   Bossemeyer D.;
RT   "Diversity of bisubstrate binding modes of adenosine analogue-oligoarginine
RT   conjugates in protein kinase a and implications for protein substrate
RT   interactions.";
RL   J. Mol. Biol. 403:66-77(2010).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) IN COMPLEX WITH AURORA KINASE
RP   INHIBITORS, PHOSPHORYLATION AT SER-11; THR-198 AND SER-339, AND MUTAGENESIS
RP   OF LYS-48; LEU-96; MET-121; VAL-124; GLN-182 AND THR-184.
RX   PubMed=21774789; DOI=10.1042/bj20110592;
RA   Pflug A., de Oliveira T.M., Bossemeyer D., Engh R.A.;
RT   "Mutants of protein kinase A that mimic the ATP-binding site of Aurora
RT   kinase.";
RL   Biochem. J. 440:85-93(2011).
RN   [41]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS), AND PHOSPHORYLATION AT THR-198 AND
RP   SER-339.
RA   Behnen J., Koester H., Ritschel T., Neudert G., Heine A., Klebe G.;
RT   "Experimental active site mapping as a starting point to fragment-based
RT   lead discovery.";
RL   Submitted (JUL-2010) to the PDB data bank.
RN   [42]
RP   X-RAY CRYSTALLOGRAPHY (1.58 ANGSTROMS).
RA   Koester H., Craan T., Brass S., Heine A., Klebe G.;
RT   "Fragment based drug design on PKA.";
RL   Submitted (SEP-2010) to the PDB data bank.
RN   [43]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-41; GLN-46 AND CYS-264.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [44]
RP   VARIANT PPNAD4 ARG-206, AND CHARACTERIZATION OF VARIANT PPNAD4 ARG-206.
RX   PubMed=24571724; DOI=10.1056/nejmoa1310359;
RA   Beuschlein F., Fassnacht M., Assie G., Calebiro D., Stratakis C.A.,
RA   Osswald A., Ronchi C.L., Wieland T., Sbiera S., Faucz F.R., Schaak K.,
RA   Schmittfull A., Schwarzmayr T., Barreau O., Vezzosi D., Rizk-Rabin M.,
RA   Zabel U., Szarek E., Salpea P., Forlino A., Vetro A., Zuffardi O.,
RA   Kisker C., Diener S., Meitinger T., Lohse M.J., Reincke M., Bertherat J.,
RA   Strom T.M., Allolio B.;
RT   "Constitutive activation of PKA catalytic subunit in adrenal Cushing's
RT   syndrome.";
RL   N. Engl. J. Med. 370:1019-1028(2014).
RN   [45]
RP   VARIANT PPNAD4 ARG-206, AND CHARACTERIZATION OF VARIANT PPNAD4 ARG-206.
RX   PubMed=24700472; DOI=10.1126/science.1249480;
RA   Cao Y., He M., Gao Z., Peng Y., Li Y., Li L., Zhou W., Li X., Zhong X.,
RA   Lei Y., Su T., Wang H., Jiang Y., Yang L., Wei W., Yang X., Jiang X.,
RA   Liu L., He J., Ye J., Wei Q., Li Y., Wang W., Wang J., Ning G.;
RT   "Activating hotspot L205R mutation in PRKACA and adrenal Cushing's
RT   syndrome.";
RL   Science 344:913-917(2014).
RN   [46]
RP   VARIANT PPNAD4 ARG-206, AND CHARACTERIZATION OF VARIANT PPNAD4 ARG-206.
RX   PubMed=24855271; DOI=10.1126/science.1252328;
RA   Sato Y., Maekawa S., Ishii R., Sanada M., Morikawa T., Shiraishi Y.,
RA   Yoshida K., Nagata Y., Sato-Otsubo A., Yoshizato T., Suzuki H.,
RA   Shiozawa Y., Kataoka K., Kon A., Aoki K., Chiba K., Tanaka H., Kume H.,
RA   Miyano S., Fukayama M., Nureki O., Homma Y., Ogawa S.;
RT   "Recurrent somatic mutations underlie corticotropin-independent Cushing's
RT   syndrome.";
RL   Science 344:917-920(2014).
RN   [47]
RP   VARIANT CAFD1 ARG-137, CHARACTERIZATION OF VARIANT CAFD1 ARG-137,
RP   INVOLVEMENT IN CAFD1, AND INTERACTION WITH PRKAR1A AND PRKAR2B.
RX   PubMed=33058759; DOI=10.1016/j.ajhg.2020.09.005;
RA   Palencia-Campos A., Aoto P.C., Machal E.M.F., Rivera-Barahona A.,
RA   Soto-Bielicka P., Bertinetti D., Baker B., Vu L., Piceci-Sparascio F.,
RA   Torrente I., Boudin E., Peeters S., Van Hul W., Huber C., Bonneau D.,
RA   Hildebrand M.S., Coleman M., Bahlo M., Bennett M.F., Schneider A.L.,
RA   Scheffer I.E., Kibaek M., Kristiansen B.S., Issa M.Y., Mehrez M.I.,
RA   Ismail S., Tenorio J., Li G., Skaalhegg B.S., Otaify G.A., Temtamy S.,
RA   Aglan M., Joench A.E., De Luca A., Mortier G., Cormier-Daire V.,
RA   Ziegler A., Wallis M., Lapunzina P., Herberg F.W., Taylor S.S.,
RA   Ruiz-Perez V.L.;
RT   "Germline and Mosaic Variants in PRKACA and PRKACB Cause a Multiple
RT   Congenital Malformation Syndrome.";
RL   Am. J. Hum. Genet. 107:977-988(2020).
CC   -!- FUNCTION: Phosphorylates and activates ABL1 in sperm flagellum to
CC       promote spermatozoa capacitation. {ECO:0000250|UniProtKB:P05132}.
CC   -!- SUBCELLULAR LOCATION: Cell projection, cilium, flagellum
CC       {ECO:0000269|PubMed:10906071}. Cytoplasmic vesicle, secretory vesicle,
CC       acrosome {ECO:0000250|UniProtKB:P05132}. Note=Expressed in the midpiece
CC       region of the sperm flagellum (PubMed:10906071). Colocalizes with
CC       MROH2B and TCP11 on the acrosome and tail regions in round spermatids
CC       and spermatozoa regardless of the capacitation status of the sperm (By
CC       similarity). {ECO:0000250|UniProtKB:P05132,
CC       ECO:0000269|PubMed:10906071}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=C-alpha-1;
CC         IsoId=P17612-1; Sequence=Displayed;
CC       Name=2; Synonyms=C-alpha-2, C-alpha-S, C(s);
CC         IsoId=P17612-2; Sequence=VSP_004759;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   CCDS; CCDS12305.1; -.
DR   RefSeq; NP_997401.1; NM_207518.2.
DR   ProteomicsDB; 53497; -.
DR   Ensembl; ENST00000589994.6; ENSP00000466651.1; ENSG00000072062.15.
DR   Ensembl; ENST00000672938.1; ENSP00000500293.1; ENSG00000288516.1.
DR   Proteomes; UP000005640; Chromosome 19.
PE   1: Evidence at protein level;
SQ   SEQUENCE   343 AA;  39822 MW;  5AD33AECC261EA16 CRC64;
     MASNSSDVKE FLAKAKEDFL KKWESPAQNT AHLDQFERIK TLGTGSFGRV MLVKHKETGN
     HYAMKILDKQ KVVKLKQIEH TLNEKRILQA VNFPFLVKLE FSFKDNSNLY MVMEYVPGGE
     MFSHLRRIGR FSEPHARFYA AQIVLTFEYL HSLDLIYRDL KPENLLIDQQ GYIQVTDFGF
     AKRVKGRTWT LCGTPEYLAP EIILSKGYNK AVDWWALGVL IYEMAAGYPP FFADQPIQIY
     EKIVSGKVRF PSHFSSDLKD LLRNLLQVDL TKRFGNLKNG VNDIKNHKWF ATTDWIAIYQ
     RKVEAPFIPK FKGPGDTSNF DDYEEEEIRV SINEKCGKEF SEF
//
